510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K073014Substantially Equivalent

Infiniti 2C9 & Vkorc1 Multiplex Assay for Warfarin

Autogenomics, Incorporated, Carlsbad CA / Abbreviated, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K073014 is the FDA 510(k) clearance record for INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARIN, a class II device, cleared for Autogenomics, Incorporated on under FDA product code ODW (Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System). FDA's definition for product code ODW reads: "An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized...". FDA records list 2 510(k) clearances for Autogenomics, Incorporated, from to . As of , FDA records show no recalls naming K073014.

Clearance record

Decision date
Received
(90 days to decision)
Product code
ODW Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Regulation
21 CFR 862.3360
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Autogenomics, Incorporated 2251 Rutherford Rd., Carlsbad CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code ODW

Trailing 12 months

FDA records hold no clearances under product code ODW in the trailing twelve months.

FDA records show no clearances under product code ODW in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code ODW, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260